Male Breast Cancer

We have extensive experience in diagnosing and managing male breast cancer, a rare condition. Our imaging specialists and pathologists, as well as surgical, radiation, and medical oncologists, collaborate to create an individualized treatment plan for you based on the type of breast cancer, the molecular features of the tumor tissue, and how advanced the cancer is. Our doctors are active in clinical trials for men with breast cancer, and you and your doctor can discuss whether enrolling in one is right for you.

Clinical Trials and Research Studies

Phase 1

A Phase 1/1b Open-Label Multi-Center Study to Characterize the Safety and Tolerability of TRQ15-01 in Patients with Relapsed/Refractory Solid Tumors and Lymphomas

Learn More

Phase 3

A phase III multicenter randomized open-label trial to evaluate efficacy and safety of ribociclib with endocrine therapy as an adjuvant treatment in patients with hormone receptor-positive HER2-negative early breast cancer (New Adjuvant TriAl with Ribociclib [LEE011]: NATALEE).

Learn More

Phase 2

Phase II trial of nivolumab with chemotherapy as neoadjuvant treatment in inflammatory breast cancer (IBC)

Learn More

Phase 3

A PHASE III RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ATEZOLIZUMAB OR PLACEBO IN COMBINATION WITH NEOADJUVANT DOXORUBICIN + CYCLOPHOSPHAMIDE FOLLOWED BY PACLITAXEL + TRASTUZUMAB + PERTUZUMAB IN EARLY HER2-POSITIVE BREAST CANCER

Learn More